Role of mucolytics in the management of COPD

References

• Adis International2003The New Ethicals CatalogueAucklandAdis Press
   Google Scholar
• BarrRGBourbeauJCamargoCA2005Tiotropium for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev2 Art. No.: CD00287610.1002/14651858.CD002876.pub2
   Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPW2000Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ320129730310807619
   PubMed Web of Science ®Google Scholar
• ColletJPShapiroPErnstP1997Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an ImmunostimulantAm J Respir Crit Care Med1561719249412546
   PubMed Web of Science ®Google Scholar
• De BenedettoFAcetoADraganiB2005Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPDPulm Pharmacol Ther1841715607126
   PubMed Web of Science ®Google Scholar
• DecramerMRutten-van MolkenMDekhuijzenPN2005Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study BRONCUS):a randomised placebo-controlled trialLancet36515526015866309
   PubMed Web of Science ®Google Scholar
• de FloraSGrassiCCaratiL1997Attenuation of influenza-like symptomatology and improvement of cell mediated immunity with long term N-acetyl cysteine treamentEur Respir J10153515419230243
   PubMed Web of Science ®Google Scholar
• DekhuijzenP2004Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary diseaseEur Respir J236293615083766
   PubMed Web of Science ®Google Scholar
• DemedtsMBehrJBuhlR2005High-dose acetylcysteine in idiopathic pulmonary fibrosisN Engl J Med35322294216306520
   PubMed Web of Science ®Google Scholar
• Ekberg-JanssonALarsonMMacneeW1999N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitisEur Respir J138293410362048
   PubMed Web of Science ®Google Scholar
• FletcherCPrideNB1984Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction:25 years on from the Ciba symposiumThorax398156701830
   PubMed Web of Science ®Google Scholar
• FriedmanMHillemanDE2001Economic burden of chronic obstructive pulmonary diseasePharmacoeconomics192455411303413
   PubMed Web of Science ®Google Scholar
• GrandjeanEMBerthetPRuffmanR2000aCost-effectiveness analysis of oral N-acetyl cysteine as a preventive treatment in chronic bronchitisPharmacol Res42395010860633
   PubMed Web of Science ®Google Scholar
• GrandjeanEMBerthetPRuffmanR2000bEfficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease:a meta-analysis of published double-blind, placebo-controlled clinical trialsClin Ther222092110743980
   PubMed Web of Science ®Google Scholar
• KasielskiMNowakD2001Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary diseaseRespir Med954485611421501
   PubMed Web of Science ®Google Scholar
• MalerbaMPonticielloARadaeliA2004Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)Pulm Pharmacol Ther17273414643168
   PubMed Web of Science ®Google Scholar
• MoherDJadadARTugwellP1996Assessing the quality of randomized controlled trials. Current issues and future directionsInt J Technol Assess Health Care121952088707495
   PubMed Web of Science ®Google Scholar
• MorettiMBottrighiPDallariR2004The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease:the EQUALIFE studyDrugs Exp Clin Res301435215553660
   PubMedGoogle Scholar
• OdderaSSilvestriMSaccoO1994N-acetylcysteine enhances in vitro the intracellular killing of Staphlyococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killingJ Lab Clin Med1242933018051494
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASMaP2001Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summaryAm J Respir Crit Care Med16312567611316667
   PubMedGoogle Scholar
• PauwelsRABuistASMaP2005Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary (Updated 2005) [online]Accessed 19 September 2005 URL:http://www.goldcopd.org
   Google Scholar
• PoolePJBlackPN2003Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev1 Art. No.: CD00128710.1002/14651858.CD001287
   Google Scholar
• RahmanIMacNeeW1996Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary diseaseThorax51348508733482
   PubMed Web of Science ®Google Scholar
• RahmanISkwarskaEMacNeeW1997Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary diseaseThorax5256589227727
   PubMed Web of Science ®Google Scholar
• RiiseGCLarssonSLarssonP1994The intrabronchial microbial flora in chronic bronchitis patients:a target for N-acetylcysteine therapy?Eur Respir J7941018143838
   PubMed Web of Science ®Google Scholar
• RogersDF2002Mucoactive drugs for asthma and COPD:any place in therapy?Expert Opin Investig Drugs111535
   PubMed Web of Science ®Google Scholar
• SadowskaAvan OverveldFJGoreckaD2005The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disase:modulation by inhaled steroids and antioxidantRespir Med99241915715193
   PubMed Web of Science ®Google Scholar
• SteyCSteurerJBachmannS2000The effect of oral N-acetyl cysteine in chronic bronchitis:a quantitative systematic reviewEur Respir J162536210968500
   PubMed Web of Science ®Google Scholar
• van OverveldFJVermierePAde BackerWA2000Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factorsInflamm Res4981310778915
   PubMed Web of Science ®Google Scholar
• VestboJPrescottELangeP1996Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidityAm J Respir Crit Care Med153153058630597
   PubMed Web of Science ®Google Scholar